作者: Ji Hyun Sim , Seung Seok Han , Dong-Sup Lee , Yon Su Kim , Hajeong Lee
DOI: 10.1016/J.TRANSPROCEED.2020.01.013
关键词:
摘要: Abstract Background Anti-thymocyte globulin (ATG) is a treatment option for steroid-resistant T-cell–mediated rejection after kidney transplantation. However, the extent to which immune-cell subsets can repopulate peripheral blood unknown. Methods Six patients with were recruited and underwent analysis of their immune cells 1 year ATG administration. Multicolor flow cytometric was used evaluate proportions T cells, B natural killer monocytes. Results T-cell repopulation from 24% 75% occurred in group. The major repopulated effector memory CD8+ followed by CD4+ cells. population low expression interleukin-7 receptor α increased over time. regulatory (eg, CD8+CD28-CD56+ CD4+CD25bright cells) populations other subsets, including monocytes, not significantly altered ATG. Conclusions Our findings on cell administration will enable future studies aiming unravel steroid-resistance mechanism underlying rejection.